
BEAM vs MRNA
$BEAM vs $MRNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BEAM vs MRNA: the quick read
- ·MRNA is the larger company by market cap ($87.04B vs $2.42B).
- ·MRNA has been more active on our scanner (266 vs 129 alerts in 30 days).
- ·BEAM has the smaller float (99.3M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·BEAM trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 266 and 129 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: MRNA is more than 36x the market cap of BEAM, so the same dollar of news moves BEAM far harder.
- ·They have diverged badly over the year: MRNA is near the top of its 52-week range while BEAM is near the bottom of its own.
- ·BEAM pays a dividend and MRNA does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BEAM and MRNA on TheDesperateTrader.
- Is BEAM or MRNA the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($87.04B vs $2.42B). MRNA has been more active on our scanner (266 vs 129 alerts in 30 days). BEAM has the smaller float (99.3M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BEAM and MRNA?
- The differences that matter: MRNA is roughly 36x the size of the other by market cap ($2.42B vs $87.04B); they trade at very different share prices ($24.00 vs $215.80); BEAM sits at 21% of its 52-week range against 88% for MRNA; only BEAM pays a dividend; our scanner flagged BEAM 129 times in the last 30 days against 266 for MRNA. Everything above is measured from the latest completed session and SEC filings.
- Which of BEAM and MRNA is more active right now?
- Right now BEAM is at about 0.8x its normal volume and MRNA is at about 1.3x, so MRNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BEAM or MRNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore BEAM and MRNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.